James D Geiger

University Of Michigan At Ann Arbor

$6,273,516

Attributed

$6,273,516

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY2005–15

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

Funding mix

By agency

FDA$5,961,480 · 1

NIH$312,036 · 3

By mechanism

P50$5,961,480 · 1

R29$308,439 · 1

P41$3,391 · 1

M01$206 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

James J Mule$10,173,865
Sem H Phan$21,667,175
Steven Lynn Kunkel$20,708,735
Alfred E Chang$7,481,608
Michael J Imperiale$14,421,971

Others in their field

Top investigators on “Dendritic Cells”

Barton F Haynes · Duke University$112,608,041
Constance Ann Benson · University Of California, San Diego$65,790,143
David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
James C. Paulson · Scripps Research Institute$41,568,802
Ulrich H Von Andrian · Harvard Medical School$32,521,007
Donald L Morton · John Wayne Cancer Institute$29,042,629

Research focus

Dendritic CellsHuman Therapy EvaluationSarcomaNeoplasm /Cancer ImmunotherapyChild (0-11)Neoplasm /Cancer VaccineNeuroblastomaPediatric Neoplasm /CancerPediatric PharmacologyFibroblastsHuman SubjectImmune Tolerance /UnresponsivenessNeoplasm /Cancer Relapse /RecurrenceActive ImmunizationAdolescence (12-20)Antigen Presenting CellAutologous TransplantationChemoattractantsChemokineClinical DepressionClinical Trial Phase ICombination Cancer TherapyT LymphocyteTransfection /Expression Vector